Cannara Biotech (CNBTF) Stock Price, News & Analysis

Company Overview

Cannara Biotech Inc. is a Canadian cannabis company that cultivates, manufactures and distributes cannabis products for the adult-use and medical markets. The company operates from Quebec and focuses on producing indoor-grown cannabis in a controlled environment.

Cannara’s product portfolio includes dried flower, pre-rolls, vape products, concentrates and other cannabis formats. Its consumer brands include Tribal, Nugz and Orchid CBD, which are marketed through authorized provincial cannabis distribution systems and retailers.

The company’s operations are centered on its cultivation and processing facilities in Quebec, supporting sales primarily in Canadian markets where its products are authorized for distribution. Cannara emphasizes product quality, consistent cultivation practices and the development of differentiated cannabis brands.

Key Stats

• Today's Range: $1.47 to $1.47
• 50-Day Range: $1.39 to $1.55
• 52-Week Range: $0.08 to $0.20
• Volume: 300 shs
• Average Volume: 33,127 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:CNBTF
• CIK: N/A
• Web: cannara.ca
• Phone: N/A
• Fax: N/A
• Employees: 13
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A